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THE APPLICATION OF FLUORESCENCE ASSAY TO THE IDENTIFICATION
OF ACIDIC COMPONENTS IN PSORIATIC LESIONS*
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It has previously been observed that when
psoriatie patients are under treatment with
hydroxystilbamidine isethionate, a bright yellow
fluorescence develops within the skin and nail
lesions (1). Subsequently, it was found that the
intensity of fluorescence could not be directly re-
lated to the amount of the diamidine present, as
shown by the fluorometric estimations of aqueous
scale extracts. It was, therefore, suggested that
the intense fluorescence of the lesions was due to
the combination of the drug with one or more sub-
stances in the psoriatic scale (2). Two groups of
chemical compounds were used for in vitro studies,
with reference to their power of combining with
hydroxystilbamidine. These were ribose nucleic
acid, their component nucleotides and certain
acid mucopolysaccharides. The choice of these
substances was made on the assumption that they
might be present in the psoriatie lesions and also
because Snapper and his associates demonstrated
that when hydroxystilbamidine localizes in mye-
loma cells, it forms complexes with nucleic acids
(3).
Fluorescence assay and spectroscopy has been
used in an attempt to identify the substance or
substances in the psoriatic scale which induce the
increased fluorescence. Characteristic fluores-
cence emission spectra of hydroxystilbamidine
alone, and after addition of ribose nucleic acid,
nucleotides, chondroitin sulfate B, heparitin
sulfate, callus and psoriatic scale extracts have
been obtained. The effect of varying the pH or of
adding inorganic salts, protein or lipid to these
solutions has been followed.
METHODS AND MATERIALS
Fluorescence measurements were made with a
Photovolt Multiplier Fluorescence Meter, Model
540. The primary filter, B. Hg-i was employed to
isolate the 365 millimicron line, as the wave length
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exciting fluorescence. For transmission of the
fluorescence light, a secondary yellow filter, B-540,
which stops light below 520 millimicrons, was
utilized. A Fluorescence Spectrum Scanner re-
placed the conventional secondary filter when
measurements of characteristic spectra were to
be carried out. In addition, a transmission type
interference filter, KD 4317 (Bausch and Lomb)
was used to isolate the 530 millimicron wave band.
Hydroxystilbamidine isethionate was obtained
from the William S. Merrell Company, Ciocinnati,
Ohio. Ribose dueleic acid, selected nueleotides
and crystalline ribonuelease, were obtained from
the Mann Research Laboratories, New York City.
Chondroitin sulphate B and heparitin sulphate
were received from The Upjohn Company, Kala-
mazoo.
All other chemicals used in this study were of
reagent grade. Aqueous extracts of callus and
psoriatic scale were made by homogenizing 200
mgm samples of defatted powdered scale (60 mesh
in the Wiley Mill) with 10 ml of distilled water in a
Waring Blendor with a semi-micro attachment for
5 minutes. The homogenate was transferred to a
Kahn shaker and agitated for 18 hours. The mix-
ture was then filtered through a Whatman No. 42
filter paper. Deproteinization of these solutions
was accomplished using triehloracetic acid.
Three series of experiments were performed:
1) The fluorescence assay of hydroxystilbami-
dine was studied in aqueous and saline solution.
The relationship of fluorescence intensity to con-
centration was followed and the quenching effects
were overcome by adequate dilution of the drug.
The effect of adding inorganic salts, varying pH
and adding protein or lipid was noted. The fluores-
cence spectrum of the drug solutions was deter-
mined.
2) Ribose nucleic acid and the nucleotides
adenylic, guanylie, eytidylic and uridylic acies
were dissolved in deionized water to give solutions
of 0.6 mgm per cent concentration. The same aque-
ous concentration was used in the ease of the
mucopolysaecharides viz: chondroitin sulfate B
and heparitin sulfate as also with uridine triphos-
phate, when this was utilized in our studies. The
fluorescence of these solutions alone and after the
addition of hydroxystilbamidine was measured.
The effect of the RNA, nueleotide, or mueopoly-
saecharide on the fluorescence intensity and
fluorescence emissioo spectrum of the drug solu-
tion was followed. The effect of pH change was
noted, using phthalate buffer solutions.
Riboouelease solutions were employed to de-
polymerize the ribose nucleic acid. It was incu-
bated with the RNA before the addition of hydrox-
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ystilbamidine. In each case, 24 hours incubation
was carried out at 36° C and optimal pH conditions
for the interaction of enzyme and substrate was
maintained. The effect of the addition of these
hydrolysed solutions on the fluorescence intensity
and emission spectrum of solutions of the aro-
matic diamidine was estimated.
3A) The fluorescence of simple aqueous ex-
tracts of psoriasis scale and callus, was deter-
mined, before and after the addition of hydroxy-
stilbamidine. (In order, to extract nucleic acid
and acid mucopolysaccharides separately from
the scale, the powdered horny material was first
extracted with 5 per cent trichloracetic acid at
90° C for 30 minutes, thus removing insoluble
protein and soluble nucleic acid. The TCA ex-
tracts were freed of the excess acid with ether,
centrifuged and filtered to remove protein and
subjected to fluorescence measurements before
and after the addition of hydroxystilbamidine.
Subsequently, aqueous extracts were made from
the scale residue and the effect of these extracts
on the fluorescence of the drug solutions was es-
timated. Protamine sulfate was added to the
aqueous extracts in an attempt to remove acid
mucopolysaccharides and after removal of the pre-
cipitate, fluorescence measurements were made;
the filtrate being added to the drug solutions.)
3B) Psoriatic scale and callus were extracted
by Flesch's method, in order to extract the epi-
dermal mucopolysaccharide fraction (4).
3C) Paper chromatography was carried out
with diamidine/RNA and diamidine/MPS (muco-
polysaccharide mixtures). The materials were
applied to Whatman No. 1 papers and one dimen-
sional descending method was employed. The
solvent system was 37 per cent propanol in an
M/15 phosphate buffer at pH 6.8. A period of 20
hours was utilized to obtain complete separation.
The dried papers were viewed under Wood's light
and photographic records were obtained.
RESULTS
When aqueous solutions of hydroxystilbami-
dine were assayed, a direct relationship between
concentration and fluorescence intensity was
found to exist for samples containing 1—10 g/ml
of the drug (Fig. 1). This relationship was unal-
tered when the drug was employed in dilute acid
solutions. The addition of inorganic salts, e.g.
sodium chloride or sodium phosphate to the solu-
tions of the aromatic diamidine did not produce
any alteration in the fluorescence intensity, until
salt concentrations above 30 ,ug/ml were reached.
There was considerable variation of fluorescence
intensity with pH. Over the range pH 3.0—7.0,
the peak fluorescence occured at pH 6.0. Addi-
tion of protein, e.g. albumin, to the solutions of
the drug, enhanced the fluorescence, due to non
specific protein absorption. Lipids and phospho-
lipids induced partial quenching. Quantitative
measurements of the relationship of lipid con-
centration to the amount of quenching was not
obtained. The maximal emission of the aqueous
solutions of hydroxystilbamidine was 525 m.
When the concentration of hydroxystilbami-
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dine in solution (0.01 mgm %) was maintained at
a constant level, but ribose nucleic acid (0.6
mgm %) was added in a volumetric ratio of hy-
droxystilbamidine : ribose nucleic acid 1:2, there
was a marked increase in the fluorescence in-
tensity but no shift in the fluorescence spectrum.
The maximum increase in the fluorescence in-
tensity was produced when solutions were
buffered to pH 6.0. Incubation of the ribose
nucleic acid solutions with RNase, prior to the
addition of the hydroxystilbamidine, markedly
reduced the fluorescence intensity of the drug-
nucleic acid mixture (Fig. 2). Addition of the
nucleotides, cytidylic, guanylic, uridylic or
adenylic acids separately to the hydroxystilbami-
dine solutions did not cause a significant increase
in the fluorescence intensity. However, the addi-
tion of uridine triphosphate to the drug solutions
did produce an increased fluorescence. There was
no shift in the fluorescence spectrum, induced by
addition, either of the ribose nucleic acid or the
uridine triphosphate. With uridine triphosphate,
the pH of the drug-nucleotide mixtures producing
maximal fluorescence was 5.4.
Heparitin sulfate and chondroitin sulfate B
added to the hydroxystilbamidine solutions,
under conditions described above for ribose nu-
cleic acid, produced a marked increase in the in-
tensity of fluorescence and a small shift in the
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fluorescence spectrum with a maximum at 530
millimicrons. The greatest increase in the in-
tensity of fluorescence was produced when the
pH of solutions was reduced to 4.2 (Fig. 3) for
chondroitin sulfate and 5.2 for heparitin sulfate.
Attempts are presently being made to depolymer-
ize these acid mucopolysaccharides enzymatically
and then to estimate the effect of the resultant
solutions on the fluorescence of the diamidine.
A marked increase in the fluorescence intensity
of hydroxystilbamidine solutions was produced
by aqueous extracts of psoriatic scale, whereas
callus extracts, prepared by identical methods,
only produced a small increase in the fluorescence
of the drug solutions. After deproteinization using
trichloracetic acid, callus solutions no longer in-
duced an increased fluorescence, whereas scale
solutions still had this effect, though the effect
was diminished. A peak of fluorescence intensity
was encountered with both psoriatic scale and
callus extracts at pH 6.0, but with psoriatic scale
another peak was found at pH 4.2 (Fig. 4). In
this acidic range only, there was a shift in the
fluorescence spectrum to 530 millimicrons. When
the psoriatic scale was treated with hot tn-
chloracetic acid and the protein precipitates and
excess trichloracetic acid removed, the resultant
solution, containing nucleic acids increased the
fluorescence intensity of the drug solutions. Sub-
FLUORESCENCE EMISSION SPECTRA
EFFECT OF RNA ON FLUORESCENCE OF HYDOXYSTILBAMIDINE
100 -
x 10
A - RNA - BOILED RNASE 1- 2HS. pH6.0
B - RNA 1- RNASE (INCUBATED) t 21-IS. p1-16.0
4
400 420 440 460 480 500 520
WAVELENGTH IN m1u
FIG. 2
90 -
(1) 80 -z
0 70 -
Lii
a: 60 -
¶? 50-
a:
Lii 40 -
0
1— 30 -0I 20 -
0 -
540 560 580 600
322 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
FLUORESCENCE EMISSION SPECTRA
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sequent aqueous extracts of the scale residue also
increased the fluorescence intensity, though to a
lesser extent. When protamine sulfate was added
to these aqueous solutions and the resultant pre-
cipitate removed, the fluorescence of the hy-
droxystilbamidine—filtrate mixtures was not sig-
nificantly increased over that of the drug alone.
Addition of the mucopolysaccharide, isolated by
Flesch's method, in aqueous solution to the by-
droxystilbamidine solutions, produced increased
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fluorescence intensity, maximal at pH 4.2 with a
shift in the emission spectrnm maximum to 530
mji (Fig. 5).
Paper chromatographic studies showed that the
aqueous extracts of psoriatic scale contained two
substances which combined with the diamidine,
one with a rate of migration identical with RNA
and the other identical with that of chondroitin
sulfate B.
DI5U55ION
These investigations have shown that hy-
droxystilbamidine has the property of combining
with ribose nucleic acid and with certain acid
mucopolysaccharides, in vitro. It also displays non-
specific absorption to proteins. Our studies have
also demonstrated that the drug combines with
ribose nucleic acid in the psoriatic scale. Since it
is known that the psoriatic horny layer contains
larger amounts of ribose nucleic acid than the
normal horny layer (5), it may be presumed that
formation of the hydroxystilbamidine—nucleic
acid complex accounts in part for the selective
affinity of the drug for the psoriatic lesions. How-
ever, it is also apparent that this is not the com-
plete picture. A substance in the psoriatic scale,
which has the characteristics of an acid mucopoly-
saccharide, also combines with the aromatic
diamidine. Our present investigations suggest
that this substance may be chondroitin sulfate B
though additional work will be necessary before
this assumption can be justified. * This finding is of
interest, since it is known that a related diamidine
amino-stilbamidine shows a special affinity for
the envelope of the spherules of Coccidioides im-
mitis (6). This envelope contains an acid muco-
polysaccharide, which as yet, has not been
chemically identified (7). The mode of action of
hydroxystilbamidine in psoriasis may then be
two-fold. The complex formation between the
drug and nucleic acid may lead to reduced epi-
dermopoeisis and thus provide an explanation for
the diminished scaling, seen in patients receiving
the drug. The characteristic changes in the
quality of the scale, from coherent masses to a
fine dry powder may be due to complex formation
between the acid mucopolysaccharide in the
epidermis and the aromatic diamidine. Thus the
cementing function of the mucopolysaceharide is
reduced. We have no direct evidence that the
formation of the acid mucopolysaccharide is re-
* It should be noted that presently available
samples of chondroitin sulfate B are not chemi-
cally pure.
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duced, though the incidental finding that uridine
triphosphate forms complexes with hydroxystil-
bamadine makes this hypothesis feasible. It has
previously been suggested by Wheatley (8) that
the demonstration of uracil in extracts of psoriatic
scale may represent a derivative of uridine diphos-
phoglucose, which is known to take part in the
synthesis of certain mncopolysaccharides (9).
SUMMARY
1. Fluorescence assay of hydroxystilbamidine
isethionate solutions has been carried out and the
maximal emission spectrum determined.
2. Complex formation between ribose nucleic
acid and the aromatic diamidine has been demon-
strated in vitro. This complex is formed optimally
at pH 6.0.
3. Similar addition products between hydroxy-
stilbamidine and the acid mucopolysaceharides,
chondroitin sulfate and heparitin sulfate have
been identified by fluorescence technics.
4. Addition of psoriatic scale extracts to the
drug solution increases the fluorescence intensity,
whereas this effect was not noted with callus ex-
tracts. The increment in fluorescence intensity,
produced by the psoriatic scale extracts was sub-
sequently shown to be due in part to the presence
of ribose nucleic acid and in part due to a muco-
polysaceharide which may be chondroitin sulfate
B.
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DISCUSSION
DR. PETER FLE5cH (Philadelphia, Pa.): Our
own data seem to support Dr. Roe's findings,
inasmuch as chondroitin sulfate B, or at least a
substance compatible with chondroitin sulfate B,
obtained from psoriatic scales was not degraded,
while a similar fraction, isolated from callus,
was almost completely decomposed.
